Document:

Exhibit 10.1

 

CONSULTING
SERVICES AGREEMENT

 

 

BY AND BETWEEN THE UNDERSIGNED:

 

MEDEURONET

 

medeuronet UK is incorporated in England & Wales with its
registered office at Leather Market, Weston Street, Bermondsey, London SE1 3ER United Kingdom. Company registration: 06591143. Represented
by Kristine A. Morrill in her capacity of Managing Director,

 

Hereinafter referred to as "MEDEURONET",

 

AND

 

Vision Care Inc,

 

With its registered office is located at VisionCare, Inc., 14395
Saratoga Ave, Suite 150, Saratoga, California 95070. Represented by Blake Michaels in his role as President and Chief Executive Officer,

 

Hereinafter referred to as "the Client",

 

MEDEURONET and the Client being also hereinafter referred to collectively
as the "Parties" and separately as the "Party".

 

	medeuronet UK is
    incorporated in England & Wales with its registered office at the Leather Market, 11/13 Weston Street, Bermondsey, London
    SE1 3ER, United Kingdom. Company registration: 06591143. www.medeuronet.com

    

    Tel: +44 203 735 8915 Email: contact@medeuronet.com

    

    BDV_01_FOR12_medeuronet Consulting Services Letter of Agreement Template_med UK_V1	

 

    

     

    

 

PREAMBLE

 

Vision Care Inc is a a privately held specialty medical device company
engaged in the research, development, manufacture, and marketing of a developed an implantable telescopic IOL that incorporates wide-angle
micro-optical lenses in a Galilean telescope design and enlarges images in front of the eye approximately 2.2 or 2.7 times their normal
size.

 

In patients with age-related macular degeneration (AMD), the magnification
allows central images to be projected onto healthy perimacular areas of the retina instead of the macula alone, where breakdown of photoreceptors
and loss of vision has occurred

 

This helps reduce the 'blind spot' and allows the patient to distinguish
and discern images that may have been unrecognizable or difficult to see.

 

The company has now developed a new 'small incision' version of the
IOL, which enables implantation through an incision of about 6.5 mm.

 

The prototype of the new IOL is CE marked and currently undergoing
clinical evaluation in Europe. In anticipation of commercially launching this version of the IOL in Europe in 2019, Vision Care is looking
to establish some level of reimbursement for the lens in order to facilitate commercial uptake

 

MEDEURONET is specialized in establishing innovative medical technologies
in the European market, focusing on market entry, including the reimbursement process.

 

As a part of its strategy, the Client wishes to partner with MEDEURONET
to begin preparations for its European clinical studies.

 

NOW, THEREFORE, in consideration thereof, the Parties agree as follows:

 

ARTICLE 1 - SUBJECT

 

This agreement (hereinafter referred to as the "Agreement")
is a consulting services agreement.

 

MEDEURONET hereby undertakes to perform the services
described in Article 2 of this Agreement in order to assist the Client in the development of its market access strategy.

 

	medeuronet UK is
    incorporated in England & Wales with its registered office at the Leather Market, 11/13 Weston Street, Bermondsey, London
    SE1 3ER, United Kingdom. Company registration: 06591143. www.medeuronet.com

    

    Tel: +44 203 735 8915 Email: contact@medeuronet.com

    

    BDV_01_FOR12_medeuronet Consulting Services Letter of Agreement Template_med UK_V1	

 

    

     

    

 

ARTICLE 2 - SERVICES

 

MEDEURONET will provide support to Vision Care, Inc., in the process
of establishing

 

1.     Market Assessment: Identifying
countries where reimbursement is available for innovative medical devices that improve quality of life, reduce the burden on public health
systems, or funds are available to enable use of new technology at surgeons' discretion.

 

 

 

2.     Execution Plan: Covering
all requirements, timelines, as well as identification of societies and opinion leaders to support the process.

 

 

 

(Hereinafter referred to as the "Services").

 

	medeuronet UK is
    incorporated in England & Wales with its registered office at the Leather Market, 11/13 Weston Street, Bermondsey, London
    SE1 3ER, United Kingdom. Company registration: 06591143. www.medeuronet.com

    

    Tel: +44 203 735 8915 Email: contact@medeuronet.com

    

    BDV_01_FOR12_medeuronet Consulting Services Letter of Agreement Template_med UK_V1	

 

    

     

    

 

ARTICLE 3 - MEDEURONET'S OBLIGATIONS

 

3.1 Performance of Services

 

MEDEURONET undertakes to provide the Services defined in Article 2
in accordance with procedures described in Article 2.

 

MEDEURONET will structure a team of specialized people to perform the
Services and undertakes to work in close collaboration with the Client.

 

MEDEURONET undertakes to answer, throughout the term of the Agreement,
orally or in writing, to any question that the Client may ask regarding the Services and to report regularly on the progress of its work.

 

MEDEURONET will provide to the Client the following for reporting:

 

-       A project plan

-       Monthly report

-       A minimum of twice monthly
team calls

 

3.2 Ownership of documents

 

Any document, report and study sent to the Client and regarding the
Services will become the sole and exclusive property of the Client.

 

3.3 Liability

 

The Parties expressly agree that MEDEURONET is merely under an obligation
to use his best endeavors. MEDEURONET is in no case liable with respect to the results.

 

MEDEURONET undertakes to provide the Services defined in Article 2
pursuant to the professional standards and in the best way possible according to the Client's expectations.

 

MEDEURONET may not be held liable, in any respect whatsoever, for any
indirect damages resulting from the provision of Services nor for any consecutive and immaterial damages.

 

In particular, MEDEURONET may not be held liable for any loss of revenue
or profit, for any operating loss or other financial damages.

 

In any case, compensation for any damages suffered by the Client resulting
    from the provision of Services may not exceed the amount of the contract as mentioned in Article 5.

 

	medeuronet UK is
    incorporated in England & Wales with its registered office at the Leather Market, 11/13 Weston Street, Bermondsey, London
    SE1 3ER, United Kingdom. Company registration: 06591143. www.medeuronet.com

    

    Tel: +44 203 735 8915 Email: contact@medeuronet.com

    

    BDV_01_FOR12_medeuronet Consulting Services Letter of Agreement Template_med UK_V1	

 

    

     

    

 

ARTICLE 4 - CLIENT'S OBLIGATIONS

 

4.1 Information and cooperation

 

The Client undertakes to provide MEDEURONET with any commercial, economic,
legal, financial, accounting information or documents or of any other nature that MEDEURONET may need regarding the provision of Services.

 

4.2 Ownership of documents

 

The Client will be the sole and exclusive owner of any document, report
or study drafted by MEDEURONET regarding the Services.

 

However, the Client may not communicate, publish nor transfer any or
part of the conclusions or results without prior express consent of MEDEURONET until the fees mentioned in Article 5 have
been fully paid by the Client to MEDEURONET.

 

ARTICLE 5 - FEES AND TERMS OF PAYMENT

 

Based on the work outlined in Article 2 above, the Parties
agree on to the following fees and terms for the provision of Services:

 

	Item	 	Budget
	EU Market Assessment:	 	 
	All deliverables as outlined	 	10,000 EUR
	 	 	 
	Execution plan:	 	 
	All deliverables as outlined —	 	15,000 to 25.000 EUR
	 	 	(depending on number of countries)

 

For the EU Market Assessment:

 

·      An
invoice 5,000 EUR will be issued upon signing of this agreement and is due upon receipt in order to commence work

·      An
invoice for the balance will be issued upon delivery of the market assessment report and is due at 10 business days.

 

	medeuronet UK is
    incorporated in England & Wales with its registered office at the Leather Market, 11/13 Weston Street, Bermondsey, London
    SE1 3ER, United Kingdom. Company registration: 06591143. www.medeuronet.com

    

    Tel: +44 203 735 8915 Email: contact@medeuronet.com

    

    BDV_01_FOR12_medeuronet Consulting Services Letter of Agreement Template_med UK_V1	

 

    

     

    

 

For the Execution plan:

 

		·	The final fee will be based on the number of
countries planned for reimbursement work and agreed between Vision Care and MEDEURONET before work begins

		·	An invoice for 50% will be issued upon commencement of this phase and is
due upon receipt

		·	An invoice for the balance will be issued upon
delivery of the market assessment report and is due at 10 business days.

 

Timeline Overview

 

 

 

ARTICLE 6 - TERM AND TERMINATION

 

This Agreement is effective as of the date of sigining and will expire
on 30 March 2019.

 

Either Party has the right to terminate this Agreement following any
breach of this Agreement by the other Party or any failure by the other Party to faithfully carry out its obligations under this Agreement;
provided that Party has had ninety (90) days to rectify any such breach or failure after receipt of notice thereof by registered letter
with acknowledgement of receipt.

 

If the 90-days' notice period for termination is invoked, any fee that
is due during this period will continue to be paid by the client.

 

ARTICLE 7-  CONFIDENTIALITY

 

The Parties agree that the contents of this Agreement shall be governed
by the following terms:

 

The Parties consider as strictly confidential any document, report,
study, data, and any information, in any form whatsoever, submitted by the other Party regarding the provision of Services (hereinafter
referred to as "Confidential Information").

 

No use. Both Parties agree not to use Confidential Information
in any way, except for the purpose of considering a transaction with the other Party hereto, nor to realize any transaction relating to
the Confidential Information except as agreed.

 

No disclosure. Both Parties agree to use their best
efforts to prevent and protect the Confidential Information, or any part thereof, from disclosure to any person other than their
employees, agents, consultants and advisors having a need for this Confidential Information in the course of their work.

 

	medeuronet UK is
    incorporated in England & Wales with its registered office at the Leather Market, 11/13 Weston Street, Bermondsey, London
    SE1 3ER, United Kingdom. Company registration: 06591143. www.medeuronet.com

    

    Tel: +44 203 735 8915 Email: contact@medeuronet.com

    

    BDV_01_FOR12_medeuronet Consulting Services Letter of Agreement Template_med UK_V1	

 

    

     

    

 

Protection of secrecy. Both Parties agree to take all steps
reasonably necessary to protect the confidentiality of this Confidential Information, and to prevent the Confidential Information from
falling into the public domain or into the possession of unauthorized persons.

 

ARTICLE 8 - STATEMENT OF MUTUAL INDEPENDANCE

 

The Parties expressly declare that they are and remain, throughout
the term of the Agreement, independent commercial and trading partners.

 

ARTICLE 9 - TRANSFER OF THE AGREEMENT

 

This Agreement has been entered into intuitu personae. It would not
be transferred or transmitted, in any way whatsoever, free of charge or against payment.

 

ARTICLE 10-  CHOICE OF LAW

 

The Parties agree that this Agreement is subject to the laws of the
United Kingdom.

 

Any dispute arising out of this Agreement shall be subject to the jurisdiction
of the courts of the United Kingdom.

 

ARTICLE 11 - ADDRESS FOR SERVICE

 

For the purpose of performing this Agreement, the Parties' addresses
are as mentioned at the top of this Agreement.

 

This Agreement will be effective as of the date of execution and the
Parties hereby demonstrate their acceptance of the terms of this Agreement by executing it on the signature lines below.

 

Signed on _27 July 2018 ___

Saratoga, CA/London

 

	/s/ Kristine A. Morrill	 	/s/ Blake Michaels
	MEDEURONET	 	The Client
	Represented by Kristine A. Morrill	 	Represented
by Blake Michaels

 

	medeuronet UK is
    incorporated in England & Wales with its registered office at the Leather Market, 11/13 Weston Street, Bermondsey, London
    SE1 3ER, United Kingdom. Company registration: 06591143. www.medeuronet.com

    

    Tel: +44 203 735 8915 Email: contact@medeuronet.com

    

    BDV_01_FOR12_medeuronet Consulting Services Letter of Agreement Template_med UK_V1Exhibit 10.2

 

VISIONCARE, INC.

 

CONSULTING AGREEMENT

 

THIS CONSULTING AGREEMENT (this “Agreement”)
is entered into effective as of November 19, 2018 (the “Effective Date”), by and between VisionCare, Inc.,
located at 14395 Saratoga Ave., Suite 150, Saratoga CA 95070, a Delaware corporation or any of its current or future subsidiaries,
affiliates, successors or assigns (collectively, the “Company”), and Prof. Dr. Albert J. Augustine, Direkor
der Augenklinik, Moltkestrasse 90, 76133 Karlsruhe, Germany (“Consultant”).

 

RECITALS

 

WHEREAS, the Company desires to retain CONSULTANT
as an independent contractor to perform consulting services for the Company from time to time, on the terms and conditions hereinafter
set forth; and

 

WHEREAS, CONSULTANT desires to perform such consulting
services and to assign to the Company the ownership of all of the results thereof, including but not limited to all intellectual property
rights therein.

 

THEREFORE, in consideration of the mutual promises
contained herein, the Company and CONSULTANT agree as follows:

 

AGREEMENT

 

1.           Services.

 

1.1            CONSULTANT
agrees to perform such duties as may be assigned to him by the Company from time to time hereafter as well as the services (if any) described
in the project assignment which is attached as Exhibit A hereto (the “Services”) in a work-manlike
manner, and according to the schedule of work set forth in such project assignment (each, a “Project Assignment”).

 

1.2           During
the term of this Agreement, CONSULTANT shall not perform consulting services in the general field of AMD Lenses for other persons, firms,
and corporations, but may provide other services provided that such services do not violate the terms of Section 9 hereof, are disclosed
as hereafter provided, and do not involve working on any project competitive with that of a Project Assignment hereunder.

 

1.3           The
term of this Agreement shall be referred to as the “Period of Consultancy”. The Period of Consultancy will commence
on the date hereof and will terminate on the 1st anniversary date hereof, unless at that time Services are being performed pursuant to
a Project Assignment which specifies a later completion date, in which case the Period of Consultancy will terminate on such completion
date.

 

    Page 1 of 9

     

    

 

2.           Payment
for Services. CONSULTANT shall be compensated in the manner set forth from time to time in a written Project Assignment.

 

3.          Relationship
of Parties. CONSULTANT shall perform the Services under the general direction of the Company, but CONSULTANT shall determine,
in CONSULTANT’s sole discretion, the manner and means by which the Services shall be accomplished, subject to the express condition
that CONSULTANT shall at all times comply with applicable law. CONSULTANT is an independent contractor and CONSULTANT is not an agent
or employee of the Company, and has no authority whatsoever to bind the Company by contract or otherwise. CONSULTANT agrees not to disrupt,
damage, impair, or interfere with the business of the Company either now or in the future, whether by way of interfering with or raiding
its employees, disrupting its relationships with customers, agents, vendors, distributors, or otherwise. During the term of this Agreement
and for one (1) year afterward, CONSULTANT agrees not to solicit any employees or customers (or customer prospects) of the Company
to work for or engage in business with any business or employer which competes with the Company, or to otherwise compete unfairly with
the Company.

 

4.           Company
Rules. CONSULTANT shall observe the working hours, working rules, and holiday schedules of the Company while working on Company’s
premises.

 

5.          Employment
Taxes and Benefits. CONSULTANT acknowledges and agrees that it shall be the obligation of CONSULTANT to report as income all compensation
received by CONSULTANT pursuant to this Agreement. CONSULTANT agrees to indemnify the Company and hold it harmless to the extent of any
obligation imposed on the Company to pay any withholding taxes, social security, unemployment or disability insurance, or similar items,
including the interest and penalties thereon, in connection with any payments made to CONSULTANT by the Company pursuant to this Agreement.

 

6.           Company
Property.

 

6.1           Definition.
For purposes of this Agreement, “Designs and Materials” will mean all designs, specifications, discoveries,
inventions, products, computer programs, deliverables, procedures, improvements, developments, drawings, notes, documents, information
and materials made, conceived or developed by CONSULTANT alone or with others which result from or relate to the Services.

 

    Page 2 of 9

     

    

 

6.2            Assignment
of Ownership. CONSULTANT hereby irrevocably transfers, conveys, sells, and assigns to the Company any and all of its worldwide
right, title, and interest in and to Designs and Materials, including but not limited to all copyrights, patent rights, trade
secrets and trademarks therein. As between the parties, the Designs and Materials will be the sole and exclusive property of the
Company and shall be considered a “work made for hire” within the meaning of 17 U.S.C. § 101 to the fullest extent
of that statute and the Company will have the sole right to determine the treatment of any Designs and Materials, including the
right to keep them as trade secrets, to file and execute patent applications on them, to use and disclose them without prior patent
application, to file registrations for copyright or trademark on them, or to follow any other procedure that the Company deems
appropriate. CONSULTANT agrees: (i) to disclose promptly in writing to the Company all Designs and Materials; (ii) to
cooperate with and assist the Company to apply for, and to execute any applications and/or assignments reasonably necessary to
obtain, any patent, copyright, trademark or other statutory protection for Designs and Materials in the Company’s or its
clients’ name as the Company deems appropriate; and (iii) to otherwise treat all Designs and Materials as
 “Confidential Information” as defined below. CONSULTANT agrees and acknowledges that it will not be
entitled to additional compensation for performing the obligations set forth in this paragraph. The obligations set forth in this
paragraph will survive any expiration or termination of this Agreement.

 

6.3          Moral
Rights Waiver. CONSULTANT hereby irrevocably transfers and assigns to the Company any and all Moral Rights that CONSULTANT may have
in any Services and Designs and Materials. CONSULTANT also hereby forever waives and agrees never to assert against the Company, its successors,
assigns, or licensees any and all Moral Rights CONSULTANT may have in any Services or Designs and Materials, even after expiration or
termination of the Period of Consultancy. For purposes of this Agreement, “Moral Rights” means any and all right to claim
authorship to or to object to any distortion, mutilation, or other modification or other derogatory action in relation to a work, whether
or not such would be prejudicial to the author’s reputation, and any similar right, existing under common or statutory law of any
country or jurisdiction in the world or under any treaty, regardless of whether or not such right is denominated or generally referred
to as a “moral right,”

 

6.4           Derivative
Works. CONSULTANT may not create any Derivative Works of the Designs and Materials without the prior written authorization of the
Company. For purposes of this Agreement, “Derivative Works” means: (i) for copyrightable material, any
translation, abridgment, revision, or other form in which such material may be recast, transformed, or adapted; (ii) for patentable
material, any improvement thereon; and (iii) for material protected by trade secret, any new material derived from such existing
trade secret material, including new material which may be protected by copyright, patent, and/or trade secret.

 

6.5           Disclosure
to Company. In order that the Company may be aware of the extent of other demands on CONSULTANT’s time and attention, CONSULTANT
agrees to disclose to Company (such disclosure to be held in confidence by the Company) the nature and scope of any other business activity
in which CONSULTANT is engaged or becomes engaged during the term of this Agreement.

 

7.           Assignment
of Copyright. In consideration of Company’s entering into this Agreement, CONSULTANT hereby assigns and transfers to
the Company, and its successors and assigns, the copyright in and to any and all Designs and Materials which were created in whole
or in part by CONSULTANT, and all right, title, and interest of CONSULTANT, whether vested and contingent, therein and thereto.

 

    Page 3 of 9

     

    

 

8.         Termination.
This Agreement shall commence on the date first written above and shall continue until terminated by either party for its convenience
upon ten (10) days written notice to the other. Unless terminated earlier, this Agreement will expire at the end of the Period of
Consultancy.

 

Upon the expiration or termination of this Agreement
for any reason, except as provided below, each party shall be released from all obligations and liabilities to the other with respect
hereto whether or not arising after the date of such termination. Notwithstanding the foregoing, no termination shall relieve CONSULTANT
or the Company, as appropriate, of their respective obligations under Sections 3, 5, 6, 7, and 9-11, nor shall any such termination relieve
CONSULTANT or the Company from any liability arising from any breach of this Agreement.

 

9.           Confidential
Information.

 

9.1           CONSULTANT
acknowledges and agrees that CONSULTANT has obtained or may now or hereafter obtain from the Company certain of the Company’s confidential
information, which confidential information includes but is not limited to all the Company’s (i) past, present, or future research,
(ii) business, development, and marketing plans, (iii) customer lists and customer relationships, (iv) prices (except where
publicly disclosed by the Company) and pricing strategies, (v) training methods, (vi) secret inventions, algorithms, processes,
methods, and specifications, (vii) compilations of information (including without limitation studies, records, reports, drawings,
memoranda, drafts, and any other related information), and (viii) source code and other software and/or trade secrets embodied in
the Company’s software and/or hardware products, (ix) product development proposals, and (x) other ideas, concepts, strategies,
designs, suggestions, and recommendations relating without limitation to any of the foregoing or to any product (including any software
or hardware product) to be developed or proposed to be developed by the Company or by the CONSULTANT and/or others for the Company (the
 “Confidential Information”). Notwithstanding the foregoing, the “Confidential Information” shall
also be deemed to include any and all confidential information of a client of the Company which CONSULTANT learns or discovers while performing
the Services hereunder, and all information, data, and materials compiled or developed by CONSULTANT for the Company prior to the Effective
Date of this Agreement. CONSULTANT further acknowledges and agrees that the Company (and/or a Company client, as appropriate) is the owner
of all such Confidential Information, any copies thereof, and of all copyright, trade secret, patent, trademark, and other intellectual
or industrial property rights therein or associated therewith. CONSULTANT (a) understands and agrees that the unauthorized use or
disclosure of the Confidential Information and any of the Company’s related intellectual and industrial property rights constitutes
unfair competition, and (b) promises not to engage in any unfair competition with the Company during the term of this Agreement or
any time thereafter.

 

    Page 4 of 9

     

    

 

9.2            CONSULTANT
agrees that for a period of five (5) years following disclosure to CONSULTANT of any Confidential Information (except, with respect
to source code and other software and/or trade secrets embodied in software, software products, or hardware, for a period of ninety-nine
(99) years), CONSULTANT will not disclose said Confidential Information or any portion thereof to any person, firm, corporation, or other
entity, or make use of such Confidential Information in any way without the Company’s prior written consent, or reverse engineer,
de-compile, or disassemble any Company (or Company client) software, software products, or hardware product containing any such software
or software products, or any portion thereof, without such consent.

 

9.3            CONSULTANT
agrees that all Confidential Information disclosed by the Company to CONSULTANT or otherwise obtained by CONSULTANT in tangible form (including
any computer software) is and shall remain the Company’s property, shall not be copied or removed from the Company’s premises
by CONSULTANT without the Company’s prior written consent, and shall be returned to the Company along with all Designs and Materials
(and any and all copies of all of the foregoing) immediately upon request therefor, or upon the termination of this Agreement, whichever
is earlier.

 

9.4          Notwithstanding
anything in Sections 9.1-9.3, CONSULTANT will not be liable for the disclosure of any of the Company’s Confidential Information
if such Information (i) is already known to CONSULTANT at the time of its first disclosure to CONSULTANT, (ii) is or becomes
publicly available other than through a breach by CONSULTANT of this Agreement, (iii) is received by CONSULTANT from a third party
if that third party has not violated the terms of any Confidentiality Agreement it may have with the Company, or (iv) is required
to be disclosed by law.

 

10.         Injunctive
Relief. Because the Services are personal and unique and because CONSULTANT will have access to Confidential Information, the
Company will have the right to enforce this Agreement and any of its provisions by injunction, specific performance or other equitable
relief without prejudice to any other rights and remedies that the Company may have for breach hereof.

 

11.         No
Patent or Similar Infringement. CONSULTANT warrants that, to the best of his knowledge, none of the Services hereunder, or their
results, infringe or will infringe any patent, copyright or trade or service mark of a third party, or misappropriate or will misappropriate
such a party’s trade secret or other proprietary rights. CONSULTANT hereby agrees to indemnify the Company and hold it harmless
from and against all damages resulting from or arising out of any action by a third party based on a breach of the foregoing warranty.

 

    Page 5 of 9

     

    

 

12.         Pre-existing
Obligations.

 

12.1          CONSULTANT
represents and warrants that CONSULTANT is not under any pre-existing obligation or obligations inconsistent with the provisions of this
Agreement, and will not enter into any agreement which conflicts with or would, if performed by CONSULTANT, cause this Agreement to be
breached.

 

12.2         If
CONSULTANT becomes aware of any actual or potential third- party claims relating to the subject matter of the Services, whether against
the Company or otherwise, CONSULTANT will immediately notify the Company of the same.

 

13.        Assignment
Restrictions. The rights and liabilities of the parties hereto shall bind and inure to the benefit of their respective successors,
executors and administrators, as the case may be, provided that, as the Company has contracted for CONSULTANT’s services, CONSULTANT
may not assign or delegate its obligations under this Agreement either in whole or in part without the prior written consent of the Company,
which may be given or withheld in the Company’s sole discretion.

 

14.        Severability.
If any provision of this Agreement shall be held to be illegal or unenforceable, such provision shall be severed from this Agreement
and the remainder thereof shall remain in full force and effect.

 

15.         Governing
Law. This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of California as
such laws would apply to agreements entered into and wholly to be performed within such state.

 

16.        Notices.
Any notices hereunder shall be in writing and shall be sent by certified or registered mail, return receipt requested, to the address
specified on the signature page or to such other address as a party specifies in writing pursuant hereto. Such notice will be effective
upon mailing if done as provided above.

 

17.        Entire
Agreement. This Agreement constitutes the entire agreement, and supersedes all previous understandings between the parties, with
respect to the subject matter hereof. This Agreement may be amended only in writing.

 

18.        Attorneys’
Fees. If any legal action is brought for the enforcement of this Agreement, or because of an alleged dispute, breach, default,
or misrepresentation in connection with any of the provisions of this Agreement, the successful or prevailing party shall be entitled
to recover reasonable attorneys’ fees and other costs incurred in that action, in addition to any other relief to which that party
may be entitled.

 

    Page 6 of 9

     

    

 

IN WITNESS WHEREOF, the parties have executed
this Agreement effective as of the date set forth above.

 

	 	COMPANY:
	 	 
	 	VISIONCARE, INC., a Delaware
    corporation
	 	 
	 	 
	 	By:	 
	 	 	Richard Powers, Executive Vice President

 

	 	Address:	14395 Saratoga Ave. Ste. 150
	 	 	Saratoga, California 95070  

 

	 	CONSULTANT:
	 	 
	 	 
	 	By:	/s/ Albert J. Augustine
	 	 	 
	 	 	 
	 	Name:	Albert J. Augustine

 

	 	Address:	Raiffeisenstrasse 5
	 	 	97320 Sulzfeld, Germany
	 	Date:	11/27/2019

 

    Page 7 of 9

     

    

 

EXHIBIT A

 

PROJECT ASSIGNMENT

 

Services. CONSULTANT agrees to perform certain services
as assigned to him by the Company from time to time (the “Services”). These services include:

 

Implantation of INT-NG Device

 

Schedule of Work. CONSULTANT shall perform the Services
according to the below schedule during the Period of Consultancy:

 

Implant 2-3 patients with the IMT-NG device

Submission of patient eligibility to Sponsor prior to implantation

Report on Adverse Events, Best Corrected Visual Acuity, OCT and Endothelial

Cell Count at pre-op. 3 month and 12 month

 

Payment for IMT-NG Surgery Services

 

Device will be provided at no cost

Surgery and reporting (as above) – 7,900€ per patient

70% on completion of surgery

30% on provision of 12 month data

 

Additional Services CONSULTANT agrees to perform certain
additional services as assigned to him by the Company from time to time (the “Services”). These services include:

 

Reimbursement activities in Germany to include meeting with our consultant,
Medeuronet, assisting them with input on the reimbursement application, and to include possible meetings with the payers.

 

Payment for Reimbursement and Other Services:

 

The Company will pay you at a rate of 2200€ per day or 350€
per hour for hourly services, plus expenses including but not limited to meals, transportation, lodging and airfare.

 

    Page 8 of 9

     

    

 

Invoices:

 

All detailed invoices should be submitted at the end of the month to:

 

AP@visioncareinc.net

Or

VisionCare, Inc.

14395 Saratoga Ave, Suite 150

Saratoga, CA 95070

 

    Page 9 of 9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00335-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00335-of-00352.parquet"}]]